ORKA
Oruka Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$93.84+1.23%
Price as of Jul 20, 2026
ORKA earnings
Oruka Therapeutics, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 10, 2026in NaN days
EPS est $-0.49 · Revenue est —
Track record
Beat EPS in 3 of 5 quarters
Avg surprise -0.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | $-0.52 | $-0.48 | +7.7% | — | — |
| Mar 12, 2026 | $-0.64 | $-0.45 | +29.3% | — | — |
| Nov 12, 2025 | $-0.56 | $-0.55 | +1.8% | — | — |
| Feb 27, 2025 | $-0.68 | $-0.96 | -41.2% | — | — |
| Nov 13, 2024 | $-0.40 | $-1.46 | -265.0% | — | — |
| Apr 25, 2024 | — | $-0.14 | — | — | — |
| Sep 29, 2022 | — | $-1.94 | — | — | — |
| Jun 29, 2019 | — | $-13.64 | — | — | — |
| Sep 29, 2018 | — | $-24.71 | — | — | — |
| Dec 30, 2017 | — | $-76.99 | — | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-10.